CNCR vs. HELX

Last updated Jun 3, 2026

CNCR (Loncar Cancer Immunotherapy ETF) and HELX (Franklin Genomic Advancements ETF) are both Health & Biotech Equities funds. CNCR is passively managed, while HELX is actively managed. CNCR charges 0.79%/yr vs 0.50%/yr for HELX.

Performance

CNCR vs. HELX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Loncar Cancer Immunotherapy ETF (CNCR) and Franklin Genomic Advancements ETF (HELX). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

CNCR

• 1D: 0.00%
• 1M: 0.00%
• YTD: —
• 6M: —
• 1Y: —
• 3Y*: —
• 5Y*: —
• 10Y*: —

HELX

• 1D: -2.11%
• 1M: 2.72%
• YTD: -5.49%
• 6M: -7.61%
• 1Y: 31.41%
• 3Y*: 4.34%
• 5Y*: -4.32%
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

CNCR vs. HELX - Yearly Performance Comparison

	2026 (YTD)
CNCR Loncar Cancer Immunotherapy ETF	0.00%
HELX Franklin Genomic Advancements ETF	-2.07%

CNCR vs. HELX - Sectors Allocation Comparison

Sectors	CNCR	HELX
Healthcare	96.6%	96.5%
Financial Services	3.3%	-
Basic Materials	-	2.7%
Communication Services	-	-
Consumer Cyclical	-	-
Consumer Defensive	-	-
Energy	-	-
Industrials	-	-
Real Estate	-	-
Technology	-	0.9%
Utilities	-	-

Return for Risk

CNCR vs. HELX — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

HELX

HELX Risk / Return Rank: 39
HELX Sharpe Ratio Rank: 43
HELX Sortino Ratio Rank: 43
HELX Omega Ratio Rank: 39
HELX Calmar Ratio Rank: 37
HELX Martin Ratio Rank: 31

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

CNCR vs. HELX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Loncar Cancer Immunotherapy ETF (CNCR) and Franklin Genomic Advancements ETF (HELX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

Sharpe Ratios by Period

	CNCR	HELX	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	—	1.51	—
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	—	-0.18	—
Sharpe Ratio (All Time) Calculated using the full available price history	—	0.22	—

Drawdowns

CNCR vs. HELX - Drawdown Comparison

The maximum CNCR drawdown since its inception was 0.00%, smaller than the maximum HELX drawdown of -58.75%. Use the drawdown chart below to compare losses from any high point for CNCR and HELX.

Drawdown Indicators

	CNCR	HELX	Difference
Max Drawdown Largest peak-to-trough decline	0.00%	-58.75%	+58.75%
Max Drawdown (1Y) Largest decline over 1 year	—	-18.01%	—
Max Drawdown (3Y) Largest decline over 3 years	—	-29.48%	—
Max Drawdown (5Y) Largest decline over 5 years	—	-58.75%	—
Current Drawdown Current decline from peak	0.00%	-40.70%	+40.70%
Average Drawdown Average peak-to-trough decline	0.00%	-34.31%	+34.31%
Ulcer Index Depth and duration of drawdowns from previous peaks	—	6.91%	—

Volatility

Volatility by Period

	CNCR	HELX	Difference
Volatility (1M) Calculated over the trailing 1-month period	—	7.00%	—
Volatility (6M) Calculated over the trailing 6-month period	—	16.24%	—
Volatility (1Y) Calculated over the trailing 1-year period	0.00%	20.89%	-20.89%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	0.00%	24.13%	-24.13%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	0.00%	27.40%	-27.40%

CNCR vs. HELX - Expense Ratio Comparison

CNCR has a 0.79% expense ratio, which is higher than HELX's 0.50% expense ratio.

Dividends

CNCR vs. HELX - Dividend Comparison

CNCR has not paid dividends to shareholders, while HELX's dividend yield for the trailing twelve months is around 0.42%.

Position	TTM	2025	2024	2023	2022	2021	2020
CNCR Loncar Cancer Immunotherapy ETF	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
HELX Franklin Genomic Advancements ETF	0.42%	0.39%	0.00%	0.00%	0.00%	0.24%	0.12%

Frequently Asked Questions

Which ETF is better, CNCR or HELX?

On fees, HELX is cheaper at 0.50% per year. The better choice depends on whether you care most about return, fees, risk, or income.

Which ETF is cheaper, CNCR or HELX?

HELX is cheaper with a 0.50% expense ratio, compared with 0.79% for CNCR.

Which ETF pays a higher dividend yield, CNCR or HELX?

HELX has the higher dividend yield at 0.42%, compared with 0.00% for CNCR.

What is the main difference between CNCR and HELX?

They also come from different issuers: Exchange Traded Concepts and Franklin Templeton. Their fees differ too: 0.79% for CNCR and 0.50% for HELX.